138 related articles for article (PubMed ID: 18950376)
1. Relationship between saliva level of 3-methoxy-4-hydroxyphenylglycol and mental health in the elderly general population.
Li GY; Watanabe I; Kunitake Y; Sugataka K; Muraoka T; Kojima N; Kawashima T; Yamada S
Psychiatry Clin Neurosci; 2008 Oct; 62(5):562-7. PubMed ID: 18950376
[TBL] [Abstract][Full Text] [Related]
2. Association between the scores on the general health questionnaire-28 and the saliva levels of 3-methoxy-4-hydroxyphenylglycol in normal volunteers.
Li GY; Ueki H; Yamamoto Y; Yamada S
Biol Psychol; 2006 Aug; 73(2):209-11. PubMed ID: 16472905
[TBL] [Abstract][Full Text] [Related]
3. Association of saliva 3-methoxy-4-hydroxyphenylglycol levels and a later depressive state in older subjects living in a rural community: 3-year follow-up study.
Watanabe I; Li GY; Imamura Y; Nabeta H; Kunitake Y; Ishii H; Haraguchi M; Kojima N; Yamada S
Int J Geriatr Psychiatry; 2012 Mar; 27(3):321-6. PubMed ID: 21538541
[TBL] [Abstract][Full Text] [Related]
4. Baseline saliva level of 3-methoxy-4-hydroxyphenylglycole (MHPG) associates with a consequent cognitive decline in non-demented elderly subjects: three-years follow-up study.
Watanabe I; Li GY; Imamura Y; Nabeta H; Kunitake Y; Ishii H; Haraguchi M; Furukawa Y; Tateishi H; Kojima N; Nizoguchi Y; Yamada S
Psychiatry Res; 2012 Feb; 195(3):125-8. PubMed ID: 21802746
[TBL] [Abstract][Full Text] [Related]
5. Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease.
Lawlor BA; Bierer LM; Ryan TM; Schmeidler J; Knott PJ; Williams LL; Mohs RC; Davis KL
Biol Psychiatry; 1995 Aug; 38(3):185-8. PubMed ID: 7578662
[TBL] [Abstract][Full Text] [Related]
6. Clinically significant depressive symptoms and associated factors in community elderly subjects from Sao Paulo, Brazil.
Barcelos-Ferreira R; Pinto JA; Nakano EY; Steffens DC; Litvoc J; Bottino CM
Am J Geriatr Psychiatry; 2009 Jul; 17(7):582-90. PubMed ID: 19546654
[TBL] [Abstract][Full Text] [Related]
7. How to calculate an MMSE score from a MODA score (and vice versa) in patients with Alzheimer's disease.
Cazzaniga R; Francescani A; Saetti C; Spinnler H
Neurol Sci; 2003 Nov; 24(4):261-7. PubMed ID: 14658044
[TBL] [Abstract][Full Text] [Related]
8. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
[TBL] [Abstract][Full Text] [Related]
9. The impact of cataract surgery on cognitive impairment and depressive mental status in elderly patients.
Ishii K; Kabata T; Oshika T
Am J Ophthalmol; 2008 Sep; 146(3):404-9. PubMed ID: 18602079
[TBL] [Abstract][Full Text] [Related]
10. The Frontal Assessment Battery (FAB): normative values in an Italian population sample.
Appollonio I; Leone M; Isella V; Piamarta F; Consoli T; Villa ML; Forapani E; Russo A; Nichelli P
Neurol Sci; 2005 Jun; 26(2):108-16. PubMed ID: 15995827
[TBL] [Abstract][Full Text] [Related]
11. Motivational symptoms of depression mask preclinical Alzheimer's disease in elderly subjects.
Bartolini M; Coccia M; Luzzi S; Provinciali L; Ceravolo MG
Dement Geriatr Cogn Disord; 2005; 19(1):31-6. PubMed ID: 15383743
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Telephone Interview for Cognitive Status (TICS) in Japanese.
Konagaya Y; Washimi Y; Hattori H; Takeda A; Watanabe T; Ohta T
Int J Geriatr Psychiatry; 2007 Jul; 22(7):695-700. PubMed ID: 17431929
[TBL] [Abstract][Full Text] [Related]
13. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
[TBL] [Abstract][Full Text] [Related]
14. [Depression and frontal dysfunction: risks for the elderly?].
Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
[TBL] [Abstract][Full Text] [Related]
15. Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
Cubała WJ; Landowski J; Wielgomas B; Czarnowski W
J Affect Disord; 2014 Jun; 161():4-7. PubMed ID: 24751300
[TBL] [Abstract][Full Text] [Related]
16. Salivary 3-methoxy-4-hydroxyphenylglycol and MRI-based volume change of the precuneus in community-dwelling elderly people.
Ohishi-Fukuchi J; Imamura Y; Orihashi R; Kunitake H; Kunitake Y; Tateishi H; Yamada S; Monji A; Mizoguchi Y
Psychogeriatrics; 2023 Jul; 23(4):675-681. PubMed ID: 37248036
[TBL] [Abstract][Full Text] [Related]
17. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
[TBL] [Abstract][Full Text] [Related]
18. Seven minute screen performance in a normal elderly sample.
Skjerve A; Nordhus IH; Engedal K; Pallesen S; Braekhus A; Nygaard HA
Int J Geriatr Psychiatry; 2007 Aug; 22(8):764-9. PubMed ID: 17152118
[TBL] [Abstract][Full Text] [Related]
19. Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer's disease.
Nagata T; Ishii K; Ito T; Aoki K; Ehara Y; Kada H; Furukawa H; Tsumura M; Shinagawa S; Kasahara H; Nakayama K
Psychiatry Clin Neurosci; 2009 Aug; 63(4):449-54. PubMed ID: 19460120
[TBL] [Abstract][Full Text] [Related]
20. Korean version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer's disease.
Na HR; Lee SH; Lee JS; Doody RS; Kim SY
Dement Geriatr Cogn Disord; 2009; 27(1):69-75. PubMed ID: 19145080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
